“Sofpironium Targets M3 Receptors In Vitro and Shows Early Clinically Meaningful Improvement in Primary Axillary Hyperhidrosis Symptoms”, J of Skin, vol. 9, no. 6, p. s717, Nov. 2025, doi: 10.25251/kvstvq23.